Content deleted Content added
again, standard, and uninteresting. Long list of drugs as in the guidelines as a footnote rather than in text. Perhaps better from the conditions though? |
No edit summary |
||
Line 5:
TMAP arose from a collaboration that began in [[1995]] between the [[Texas Department of Mental Health and Mental Retardation]] (TDMHMR), [[pharmaceutical]] companies, and the [[University of Texas Southwestern Medical Center at Dallas|University of Texas Southwestern]]. According to the ''British Medical Journal'', "the project (TMAP) was funded by a [[Robert Wood Johnson Foundation|Robert Wood Johnson]] grant (along with several drug companies)." The research was supported by the National Institute of Mental Health, the Robert Wood Johnson Foundation, the Meadows Foundation, the Lightner-Sams Foundation, the Nanny Hogan Boyd Charitable Trust, TDMHMR, the Center for Mental Health Services, the Department of Veterans Affairs, the Health Services Research and Development Research Career Scientist Award, the United States Pharmacopoeia Convention Inc. and Mental Health Connections.
The companies which produce and market the drugs(1) recommended as standard treatments
Similar algorithms and prescribing advice have been produced elsewhere, for instance at the [[Maudsley Hospital]]<ref>[http://www.mhc.com/Algorithms/AlgoLinks.HTML] Lists of Psychopharmacology Algorithms. Compiled by David N. Osser, M.D. and Robert D. Patterson, M.D. (viewed 17 March 2006)</ref>, London.
| |||